Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Accelerated Approval - what are the chances?

<< Previous

Bullboard Posts

Next >>

Comment by Infinityon Dec 09, 2022 4:13am

300 Views

Post# 35161031

RE:Accelerated Approval - what are the chances?

Thanks Eog, You have hit the nail on the head so to speak. I believe you have done your research better than many others on this board. Thank you for your time and sharing your thoughts.

May I ask you to publish the results for the first 12 under treated patients. I understand that many are still in the clinical program and continuing to place their trust with Theralase and TLD 1433 inspite of the initial fiasco with bladder volume calculations.

<< Previous

Bullboard Posts

Next >>

NTG Clarity Networks' growth story continues with $22M contract